[{"Assets_0_Q3_USD":247693000.0,"CommonStockSharesOutstanding_0_Q3_shares":32516041.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-49301000.0,"NetIncomeLoss_1_Q3_USD":-27568000.0,"NetIncomeLoss_3_Q3_USD":-70146000.0,"StockholdersEquity_0_Q3_USD":225089000.0,"Ticker":"MRTX","CIK":"1576263","name":"MIRATI THERAPEUTICS, INC.","OfficialName":"Mirati Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4261498445.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]